Miranda Jayne Toledano
CIK 1686530 · Chief Executive Officer · last filed 2026-07-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.24M
Companies
5
Total Filings
22
Lifetime Open-Market Net
$122.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ENTX | Chief Executive Officer | 774,142 | $3.26 | $2.52M | $36.9K | 6 | 2026-07-16 |
| DERM | Director | 168,618 | $6.31 | $1.06M | $0 | 8 | 2026-07-02 |
| NXGLW | Director | 1,819 | $0.02 | $28 | $10.0K | 2 | 2023-08-21 |
| Entera Bio Ltd. (ENTXW) Delisted | Chief Executive Officer | 86,800 | $0.00 | $104 | $75.9K | 5 | 2023-04-06 |
| CMPX | Director | 1,791,549 | $2.04 | $3.65M | $0 | 1 | 2021-06-29 |
Recent Filings · Page 2 of 3
22 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-14 | ENTX | Grant (A) | — | $0 | EDGAR |
| 2023-08-21 | NXGLW | Grant (A) | — | $0 | EDGAR |
| 2023-07-25 | DERM | Grant (A) | +27,472 | $0 | EDGAR |
| 2023-04-06 | Entera Bio Ltd. (ENTXW) Delisted | Buy (P) | +30,000 | $30.3K | EDGAR |
| 2022-11-14 | Entera Bio Ltd. (ENTXW) Delisted | Buy (P) | +50,000 | $26.6K | EDGAR |
| 2022-09-09 | Entera Bio Ltd. (ENTXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-07-25 | DERM | Grant (A) | +14,245 | $0 | EDGAR |
| 2022-04-04 | DERM | Grant (A) | +30,000 | $0 | EDGAR |
| 2022-01-19 | Entera Bio Ltd. (ENTXW) Delisted | Buy (P) | +6,800 | $19.0K | EDGAR |
| 2022-01-11 | Entera Bio Ltd. (ENTXW) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.